浏览全部资源
扫码关注微信
1. 湖北中医药大学针灸骨伤学院
2. 湖北中医药大学基础医学院
纸质出版日期:2020
移动端阅览
陈丽, 王静芝, 周广文, 等. 电针对肥胖大鼠肠道Toll样受体4和核转录因子κB的影响[J]. 针刺研究, 2020,45(7):541-547.
CHEN Li, WANG Jing-zhi, ZHOU Guang-wen, et al. Effect of electroacupuncture on intestinal Toll-like receptor 4 and nuclear factor-kappa B in obese rats[J]. Acupuncture research, 2020, 45(7): 541-547.
陈丽, 王静芝, 周广文, 等. 电针对肥胖大鼠肠道Toll样受体4和核转录因子κB的影响[J]. 针刺研究, 2020,45(7):541-547. DOI: 10.13702/j.1000-0607.190736.
CHEN Li, WANG Jing-zhi, ZHOU Guang-wen, et al. Effect of electroacupuncture on intestinal Toll-like receptor 4 and nuclear factor-kappa B in obese rats[J]. Acupuncture research, 2020, 45(7): 541-547. DOI: 10.13702/j.1000-0607.190736.
目的:观察电针对肥胖大鼠肠道组织Toll样受体4(TLR4)和核转录因子κB(NF-κB)的影响
探讨针灸减肥的作用机制。方法:Wistar雄性大鼠随机分为正常组和模型组
高脂饲料喂养建立肥胖大鼠模型
造模成功的24只大鼠随机分为模型组、抑制剂组和电针组
每组8只。电针治疗选取"关元""中脘""足三里"和"丰隆"
每次治疗10 min
抑制剂组采用TAK-242腹腔注射
每周3次
共干预8周。每2周测量1次体质量和血糖
免疫共沉淀法测定肠道组织TLR4和NF-κB p65相互作用
凝胶迁移实验法测定肠道组织NF-κB p65活性
Western blot法测定肠道组织TLR4、NF-κB p65和p-IκBα蛋白表达
实时荧光定量PCR测定肠道组织TLR4、NF-κB p65和IκBαmRNA表达。结果:与对照组比较
模型组体质量、血糖水平、TLR4、NF-κB p65、p-IκBα的蛋白和mRNA水平均显著升高(P<0.01
P<0.05)
TLR4与NF-κB p65结合能力及NF-κB p65活性显著增强(P<0.05
P<0.01)。与模型组比较
电针组大鼠体质量显著降低(P<0.05)
电针组和抑制剂组干预后餐后血糖水平、TLR4、NF-κB p65、p-IκBα的蛋白和mRNA水平显著降低(P<0.05
P<0.01)
NF-κB p65活性显著减弱(P<0.01)。结论:电针能够有效调控肠道TLR4
抑制其与NF-κB p65相互作用
降低NF-κB p65活性
这可能是电针降低肥胖大鼠体质量和血糖水平
从而改善其肥胖状态的潜在机制之一。
Objective To investigate the effect of electroacupuncture(EA) on intestinal Toll-like receptor 4(TLR4) and nuclear factor-kappa B(NF-κB) in obese rats
so as to explore the mechanism of action of acupuncture in losing weight. Me-thods A total of 50 male Wistar rats were randomly divided into control and model groups. High-fat feed was used to establish a rat model of obesity
and after modeling
the 24 rats were randomly divided into model group
TLR4 inhibitor group
and EA group
with 8 rats in each group. The rats in the EA group were given EA at "Guanyuan"(CV4)
"Zhongwan "(CV12)
"Zusanli"(ST36)
and" Fenglong"(ST40)
10 minutes each time
3 times a week
and those in the TLR4 inhibitor group were given intraperitoneal injection of TAK-242 three times a week; the course of treatment was 8 weeks for both groups. Body weight and blood glucose were measured every two weeks. Co-immunoprecipitation was used to observe the interaction between TLR4 and NF-κB p65 in the intestinal tissue; electrophoretic mobility shift assay was used to measure the activity of NF-κB p65; Western blot was used to measure the protein expression of TLR4
phosphorylated nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha(p-IκBα)
and NF-κB p65; quantitative real-time PCR was used to measure the mRNA expression of TLR4
NF-κB p65
and IκBα. Results Compared with the control group
the model group had significant increases in body weight
blood glucose
and protein and mRNA expression of TLR4 and NF-κB p65(P<0.01
P<0.05)
as well as significant enhancement in the interaction between TLR4 and NF-κB p65 and activity of NF-κB p65(P<0.05
P<0.01). Compared with the model group
the EA group had a significant reduction in body weight(P<0.05)
both of the EA group and the TLR4 inhibitor group had significant reductions in blood glucose
and protein and mRNA expression of TLR4
p-IκBα
and NF-κB p65(P<0.05
P<0.01)
as well as significant reductions in the activity of NF-κB p65(P<0.01). Conclusion EA can effectively regulate intestinal TLR4
inhibit the interaction between TLR4 and NF-κB p65
and reduce the activity of NF-κB p65
which may be a potential mechanism of EA in reducing body weight and blood glucose in obese rats.
0
浏览量
464
下载量
5
CNKI被引量
关联资源
相关文章
相关作者
相关机构